Table 1 Baseline characteristics of study cohort and vaccination status.
Characteristic | Overall N = 24741641 | Vaccination status | p-value2 | ||
|---|---|---|---|---|---|
Unvaccinated N = 12380401 | Partially vaccinated with BNT162b2 N = 1365701 | Fully vaccinated with BNT162b2 N = 10995541 | |||
Age | < 0.001 | ||||
6 | 200,046 (8.1%) | 124,803 (10%) | 9989 (7.3%) | 65,254 (5.9%) | |
7 | 454,873 (18%) | 247,958 (20%) | 24,763 (18%) | 182,152 (17%) | |
8 | 457,304 (18%) | 234,285 (19%) | 24,939 (18%) | 198,080 (18%) | |
9 | 451,910 (18%) | 221,276 (18%) | 24,890 (18%) | 205,744 (19%) | |
10 | 460,834 (19%) | 212,734 (17%) | 25,628 (19%) | 222,472 (20%) | |
11 | 449,197 (18%) | 196,984 (16%) | 26,361 (19%) | 225,852 (21%) | |
Male | 1,268,584 (51%) | 639,505 (52%) | 70,700 (52%) | 558,379 (51%) | < 0.001 |
Ethnicity | < 0.001 | ||||
Malay | 1,567,392 (63%) | 923,837 (75%) | 91,689 (67%) | 551,866 (50%) | |
Chinese | 332,064 (13%) | 15,223 (1.2%) | 9846 (7.2%) | 306,995 (28%) | |
Indian | 121,706 (4.9%) | 71,869 (5.8%) | 8202 (6.0%) | 41,635 (3.8%) | |
Others | 453,002 (18%) | 227,111 (18%) | 26,833 (20%) | 199,058 (18%) | |
Region3 | < 0.001 | ||||
Northern region | 484,762 (20%) | 262,959 (21%) | 26,293 (19%) | 195,510 (18%) | |
Central region | 719,809 (29%) | 323,855 (26%) | 46,981 (34%) | 348,973 (32%) | |
Southern region | 373,542 (15%) | 150,866 (12%) | 21,011 (15%) | 201,665 (18%) | |
Eastern region | 418,954 (17%) | 297,624 (24%) | 16,188 (12%) | 105,142 (9.6%) | |
Sabah and Sarawak | 476,473 (19%) | 202,432 (16%) | 26,071 (19%) | 247,970 (23%) | |
Unknown | 624 | 304 | 26 | 294 | |
Duration between vaccines (days) | 60.7 (13.8) | – | – | 60.7 (13.8) | < 0.001 |
Infected* | 16,491 (0.7%) | 4776 (0.4%) | 901 (0.7%) | 10,814 (1.0%) | < 0.001 |
History of infection* | 101,442 (4.1%) | 43,872 (3.5%) | 7088 (5.2%) | 50,482 (4.6%) | < 0.001 |
Hospital admission** | 688 (< 0.1%) | 414 (< 0.1%) | 45 (< 0.1%) | 229 (< 0.1%) | < 0.001 |
